La Lingua Nostra La Lingua Nostra
Arama Sonuçları
Tüm Sonuçları Gör
  • Katıl
    Giriş yapın
    Başvur
    Site içinde arama yapın
    Night Mode

Site içinde arama yapın

Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek

  • Web sayfası bildirimcisi
  • EXPLORE
  • Sayfalar
  • Gruplar
  • Events
  • Blogs
  • Offers
  • Jobs
  • Yazı
  • Articles
  • Kullanıcılar
  • Sayfalar
  • Gruplar
  • Events
  • Emma Verghise bir dosya eklendi Other
    2025-08-14 10:21:53 -
    Academic-Industry-CRO Triangles: Collaborative Discovery Ecosystems Across U.S. Research Hubs
    The U.S. small molecule drug discovery outsourcing market, valued at USD 1.49 billion in 2024, is projected to grow at a compound annual growth rate (CAGR) of 9.48% from 2025 to 2034, driven by escalating R&D costs, talent scarcity, and the pharmaceutical industry’s strategic shift toward externalized innovation. As biopharma companies face mounting pressure to accelerate drug...
    0 Yorumlar 0 hisse senetleri 912 Views 0 önizleme
    Please log in to like, share and comment!
  • Emma Verghise bir dosya eklendi Home
    2025-08-14 10:00:22 -
    Global Talent Arbitrage: Accessing Skilled Chemists and Biologists Through Offshore Partnerships
    The global small molecule drug discovery outsourcing market, valued at USD 4.48 billion in 2024, is anticipated to expand at a CAGR of 9.68% from 2025 to 2034, with growth increasingly driven by segment-wise performance across service types, therapeutic areas, and technological platforms. Unlike biologics development, which relies heavily on biological systems, small molecule discovery remains...
    0 Yorumlar 0 hisse senetleri 965 Views 0 önizleme
    Please log in to like, share and comment!
  • Rutuja Bhosale bir dosya eklendi Other
    2025-12-05 04:43:49 -
    What is the Drug Discovery Outsourcing Market Size in 2025 and Beyond?
    Drug Discovery Outsourcing Market: Comprehensive Overview, Trends, and Forecast  The Drug Discovery Outsourcing Market is experiencing robust expansion as pharmaceutical and biotechnology companies increasingly rely on specialized contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) to accelerate innovation, reduce costs, and...
    0 Yorumlar 0 hisse senetleri 18 Views 0 önizleme
    Please log in to like, share and comment!
© 2025 La Lingua Nostra Turkish
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Koşullar Gizlilik Contact Us Rehber